Jakemans Throat and Chest Cherry

Description

JAKEMANS is a throat and chest lozenge that has been manufactured in Boston, England, since 1907. Each package contains 24 lozenges, which are cherry-flavored and include other natural flavors. The formulation features menthol as a cough suppressant and provides oral anesthetic properties. JAKEMANS is produced using high-quality natural ingredients, maintaining a tradition of excellence for over a century.

Uses and Indications

This drug is indicated for the treatment of persistent or chronic cough associated with smoking, asthma, or emphysema. It is also indicated for cough that occurs with excessive phlegm (mucus).

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 2 years and older should dissolve one lozenge slowly in the mouth. This process may be repeated every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, it is advised to consult a doctor before administration.

Contraindications

Use is contraindicated in patients who experience a cough that persists for more than one week, recurs, or is accompanied by fever, rash, or persistent headache, as these symptoms may indicate a serious underlying condition. Additionally, discontinue use and consult a healthcare professional if symptoms of a sore mouth do not improve within 7 days.

Warnings and Precautions

Patients should be aware of the potential for sore throat as a significant warning associated with this treatment. In cases where the sore throat is severe, persists for more than two days, or is accompanied or followed by symptoms such as fever, headache, rash, swelling, nausea, or vomiting, it is imperative to consult a healthcare professional promptly.

Additionally, patients are advised to discontinue use and seek medical advice under the following circumstances: if a cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache. A persistent cough may indicate a serious underlying condition that requires further evaluation. Furthermore, if symptoms of a sore mouth do not show improvement within seven days, it is essential to contact a healthcare provider for further assessment and guidance.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. Notably, a sore throat is a common warning; if the sore throat is severe, persists for more than 2 days, or is accompanied or followed by symptoms such as fever, headache, rash, swelling, nausea, or vomiting, patients are advised to consult a doctor promptly.

Additionally, patients should stop use and seek medical advice if a cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition. Furthermore, if symptoms of a sore mouth do not improve within 7 days, it is recommended that patients consult a healthcare professional.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Jakemans Throat and Chest Cherry (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the lozenge should be dissolved slowly in the mouth. Dosing may be repeated every 2 hours as needed or as directed by a healthcare provider.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

Serious adverse events have been reported voluntarily or through surveillance programs. Healthcare professionals and patients are encouraged to report any serious adverse events to the designated contact number: 1-866-205-1185.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion.

Patients should be instructed to stop using the medication and consult a doctor if their cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache. It is important to communicate that a persistent cough may indicate a serious underlying condition that requires medical evaluation.

Additionally, patients should be informed to seek medical advice if symptoms of a sore mouth do not improve within 7 days, as this may necessitate further investigation and management.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is recommended to store the product at room temperature to maintain its efficacy.

To ensure optimal preservation, the product must be protected from light exposure. Additionally, it is crucial to keep the container tightly closed when not in use to prevent contamination and degradation. Once opened, the product should be discarded after use to ensure safety and effectiveness.

Additional Clinical Information

The medication is administered orally, with adults and children aged 2 years and older instructed to dissolve the lozenge slowly in the mouth. Dosing may be repeated every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, consultation with a doctor is recommended prior to use.

There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Jakemans Throat and Chest Cherry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)